Matthew J. Ahearne
University of Leicester(GB)Leicester Royal Infirmary(GB)University Hospitals of Leicester NHS Trust(GB)NIHR Leicester Biomedical Research Centre(GB)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, SARS-CoV-2 and COVID-19 Research, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study(2022)88 cited
- → Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma(2021)84 cited
- Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients(2022)
- → Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia(2013)69 cited
- → The role of BCL6 in lymphomas and routes to therapy(2010)68 cited
- → Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma(2014)67 cited
- → Follicular helper T‐cells: expanding roles in T‐cell lymphoma and targets for treatment